PROK 8-K 2026-10-29

PROKIDNEY CORP. (PROK) 8-K dated 2026-10-29 — accession 0001193125-26-438071.

PROKIDNEY CORP. (PROK) is a biotechnology company listed on US.

PROKIDNEY CORP. filed a 8-K on 2026-10-29. Accession 0001193125-26-438071.

This 8-K covers: Material agreement (Item 1.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PROK revenue for 2025-12-31 was $893.0K. Net income was -$69.0M. Revenue was up 1075.0% from 2024-12-31 to 2025-12-31. PROK currently screens at market cap $543.7M.

Not investment advice. The PROK SEC hub lists recent forms. The stock page is the research view.